Relationship between the development of autoimmunity and sensorimotor gating in MRL-Ipr mice with reduced IL-2 production

被引:11
作者
Petitto, JM
Huang, Z
Lo, J
Beck, RD
Rinker, C
Hartemink, DA
机构
[1] Univ Florida, Coll Med, McKnight Brain Inst, Dept Psychiat, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, McKnight Brain Inst, Dept Pharmacol, Gainesville, FL 32610 USA
关键词
autoimmunity; lupus; cytokines; forebrain; sensorimotor gating; prepulse inhibition;
D O I
10.1016/S0304-3940(02)00545-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
MRL-Ipr mice develop systemic lupus-like autoimmune disease associated with changes in emotional reactivity and spatial learning and memory. Although the major immunological deficit in MRL-Ipr mice is uncontrolled lymphoproliferation associated with a Fas gene mutation, these mice have a marked deficit in interleukin-2 (IL-2) production which, when treated, can prevent the development of autoimmune disease. Moreover, both MRL-Ipr and IL-2 knockout mice manifest alterations in hippocampal cytoarchitecture and cognitive behavior. We found previously that IL-2 knockout mice have alterations in prepulse inhibition (PPI), a measure of sensorimotor gating. Thus, the present study sought to test the hypothesis that that PPI would be altered in MRL-Ipr mice. Compared to MRL+/+ control mice, MRL-Ipr mice exhibited different patterns of PPI during development. Whereas 7 and 12-week MRL-Ipr mice with evidence of autoimmune disease (the onset and early stages, respectively) showed increased PPI, 5 week predisease MRL-Ipr mice did not. MRL-Ipr mice also exhibited increased acoustic startle reactivity that was independent of autoimmune disease. These behavioral changes were not associated with increased brain expression of the proinflammatory cytokines genes, IL-1 a and IL-6 CID3, or c-myc-associated apoptosis. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:304 / 308
页数:5
相关论文
共 21 条
[1]   ENHANCED TRANSCRIPTION OF C-MYC PROTO-ONCOGENE IN SPLEEN LYMPHOCYTES FROM LUPUS-PRONE MICE DURING THE GROWING PROCESS [J].
DEGUCHI, Y ;
KISHIMOTO, S .
FEBS LETTERS, 1989, 259 (01) :158-160
[2]  
GANGULI R, 1995, ARCH GEN PSYCHIAT, V52, P668
[3]   TREATMENT WITH IL2/VACCINIA RECOMBINANT VIRUS LEADS TO SEROLOGIC, HISTOLOGIC AND PHENOTYPIC NORMALIZATION OF AUTOIMMUNE MRL/LPR-LPR MICE [J].
GUTIERREZRAMOS, JC ;
ANDREU, JL ;
MARCOS, MAR ;
VEGAZO, IR ;
MARTINEZ, C .
AUTOIMMUNITY, 1991, 10 (01) :15-25
[4]   SOD1 down-regulates NF-κB and c-mye expression in mice after transient focal cerebral ischemia [J].
Huang, CY ;
Fujimura, M ;
Noshita, N ;
Chang, YY ;
Chan, PH .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (02) :163-173
[5]   RESTORATION OF AN EARLY, PROGRESSIVE DEFECT IN RESPONSIVENESS TO T-CELL ACTIVATION IN LUPUS MICE BY EXOGENOUS IL-2 [J].
HUANG, FP ;
STOTT, DI .
AUTOIMMUNITY, 1993, 15 (01) :19-29
[6]   Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-β1 gene therapy using attenuated Salmonella typhimurium as gene carrier [J].
Huggins, ML ;
Huang, FP ;
Xu, D ;
Lindop, G ;
Stott, DI .
LUPUS, 1999, 8 (01) :29-38
[7]   Elevated plus maze behavior, auditory startle response, and shock sensitivity in predisease and in early stage autoimmune disease MRL/lpr mice [J].
Nielsen, DM ;
Crnic, LS .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (01) :46-61
[8]  
Petitto J.M., 2001, PSYCHONEUROIMMUNOLOG, V2, P173
[9]  
Petitto JM, 1999, J NEUROSCI RES, V56, P441, DOI 10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.3.CO
[10]  
2-7